EcoDrugPlus

Ensembl ID : ENSDLAG00005025394
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSDLAG00005025454
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSDLAG00005025459
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSDLAG00005025464
Gene Symbol: -
Cross references: -
254 Possible Orthologues:

Ensembl ID : ENSDLAG00005025499
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSDLAG00005025591
Gene Symbol: -
Cross references: -
219 Possible Orthologues:

Ensembl ID : ENSDLAG00005025730
Gene Symbol: -
Cross references: -
258 Possible Orthologues:

Ensembl ID : ENSDLAG00005025733
Gene Symbol: -
1 Cross references
196 Possible Orthologues:

Ensembl ID : ENSDLAG00005025736
Gene Symbol: -
Cross references: -
216 Possible Orthologues:

Ensembl ID : ENSDLAG00005025952
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSDLAG00005025985
Gene Symbol: -
Cross references: -
143 Possible Orthologues:

Ensembl ID : ENSDLAG00005026082
Gene Symbol: -
Cross references: -
223 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).